Journal
/
/
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Journal JoVE
Biologie
Author Produced
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Biologie
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
DOI:

08:32 min

August 09, 2022

, , , , ,

Chapitres

  • 00:04Introduction
  • 00:53Gene Editing of HSPCs
  • 02:55Transplantation of Gene-Edited HSPCs
  • 04:39Assessment of Short-Term Engraftment Potential
  • 05:17Assessment of Long-Term Engraftment Potential
  • 07:01Results: Evaluating the Efficiency of CRISPR/Cas9 Gene Editing of HSPCs
  • 07:58Conclusion

Summary

Traduction automatique

The present protocol describes an optimized hematopoietic stem and progenitor cell (HSPC) culture procedure for the robust engraftment of gene-edited cells in vivo.

Vidéos Connexes

Read Article